Stocks/ING

ING three-lens brief

Evidence-based stock research on ING. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$22.40$32.54$32.99

Performance

1W
+1.4%
1M
+12.7%
3M
+13.4%
6M
+15.0%
YTD
+16.2%
1Y
+41.5%
3Y
5Y
ING · Nightly brief
Watch

50-day MA above 200-day MA (golden-cross regime); price above both. · Trading at 96% of its 52-week range — near the top of the band.

  • Trading at 96% of its 52-week range — near the top of the band.
  • 50-day MA above 200-day MA (golden-cross regime); price above both.
  • Earnings scheduled 2026-07-30.

ING closed at $32.54 (+0.12%) as of 2026-07-10. Market cap: $93.05B. P/E (trailing) 13.1. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: trading at 96% of its 52-week range — near the top of the band.. Last quarter: Revenue $5.82B, net income $1.56B. Watching for: 2026-07-30 earnings release (19 days out).

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on ING, not one.

A single reasoning model has blind spots it doesn’t know about. We examine INGacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ING"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ING brief"></iframe>